NIH Weekly Funding Opportunities and Policy Notices

Thursday, February 1, 2018 - 10:11am
Funding Opportunity PA-18-623 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage research grant applications that propose to develop or substantially modify existing cutting-edge tools that will advance prenatal and/or pediatric hydrocephalus research. The primary objective of this FOA is to remove barriers to hydrocephalus research that are due to scarcity of tools to investigate both the disease mechanisms and alternative therapies (non-shunt) in a rigorous manner. Applications should aim to transform the field of prenatal and/or pediatric hydrocephalus research by generating tools including animal and cell models, novel methods and innovative technologies that will be widely used throughout the neuroscience community to understand disease mechanisms and/or developing therapeutics.
Thursday, February 1, 2018 - 9:41am
Funding Opportunity PAR-18-616 from the NIH Guide for Grants and Contracts. The purpose of the Funding Opportunity Announcement (FOA) is to support research projects using a Traceback approach to genetic testing to identify unaffected individuals at increased risk for cancer in different clinical contexts and communities, including racially/ethnically diverse populations.
Thursday, February 1, 2018 - 9:19am
Funding Opportunity PA-18-619 from the NIH Guide for Grants and Contracts. The purpose of this FOA is encourage applications that seek to examine processes of recovery and relapse in the treatment of Alcohol Use Disorders. Applications high in innovation and significance are highly encouraged that address the following potential topics: 1) defining recovery; 2) Examining new and innovative methods to examine precipitants of relapse; 3) Understanding mechanisms of mutual help and recovery; 4) Evaluating recovery systems of care; and 5) Examining processes of extended treatment for AUD.
Thursday, February 1, 2018 - 8:18am
Funding Opportunity PA-18-615 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for innovative basic and translational research projects examining HIV infection, persistence, and comorbidities as they relate to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR) in NOT-OD-15-137.
Thursday, February 1, 2018 - 7:39am
Notice NOT-CA-18-052 from the NIH Guide for Grants and Contracts
Thursday, February 1, 2018 - 7:06am
Notice NOT-DA-18-060 from the NIH Guide for Grants and Contracts
Thursday, February 1, 2018 - 1:03am
Funding Opportunity RFA-GM-18-002 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs and foster a better understanding of biomedical, behavioral and clinical research and its implications.
Wednesday, January 31, 2018 - 11:15pm
Funding Opportunity PAR-18-618 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only SBIR Phase II and Fast-Track applications are supported under this program. SBIR Phase I applications are only accepted as part of a Fast-track application.
Wednesday, January 31, 2018 - 10:42am
Funding Opportunity RFA-HD-19-017 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to announce the re-competition of the National Centers for Translational Research in Reproduction and Infertility (NCTRI). The NCTRI will be administered through the Specialized Research Center (P50) award mechanism. These centers will form a national network that facilitates and accelerates bidirectional knowledge transfer between the laboratory and clinic with the ultimate goal of improving human reproductive and gynecological health through research excellence and innovation.
Wednesday, January 31, 2018 - 8:54am
Funding Opportunity PAR-18-612 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to support studies on electronic nicotine delivery systems (ENDS) that examine population-based, clinical and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, benefits and impacts on other tobacco use behavior among different populations.
Wednesday, January 31, 2018 - 8:54am
Funding Opportunity PAR-18-611 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to support studies on electronic nicotine delivery systems (ENDS) that examine population-based, clinical and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, benefits and impacts on other tobacco use behavior among different populations.
Wednesday, January 31, 2018 - 7:48am
Notice NOT-AG-18-002 from the NIH Guide for Grants and Contracts
Wednesday, January 31, 2018 - 7:10am
Funding Opportunity PA-18-610 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications from small business concerns for Small Business Innovation Research (SBIR) projects that propose innovative research and development of technology for cryogenic or other long-term preservation and revival of Drosophila and zebrafish genetic stocks. The proposed technologies should be reliable, reproducible and cost effective for the long-term preservation and revival of wild type and laboratory created genetic stocks.
Wednesday, January 31, 2018 - 7:10am
Funding Opportunity PA-18-609 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications from small business concerns for Small Business Technology Transfer (STTR) projects that propose innovative research and development of technology for cryogenic or other long-term preservation and revival of Drosophila and zebrafish genetic stocks. The proposed technologies should be reliable, reproducible and cost effective for the long-term preservation and revival of wild type and laboratory created genetic stocks.
Wednesday, January 31, 2018 - 5:40am
Notice NOT-TW-18-004 from the NIH Guide for Grants and Contracts
Wednesday, January 31, 2018 - 5:25am
Notice NOT-OD-18-127 from the NIH Guide for Grants and Contracts
Tuesday, January 30, 2018 - 11:16pm
Funding Opportunity PA-18-614 from the NIH Guide for Grants and Contracts. The Mentored Career Transition Award for NIMH Intramural Fellows (K22) is a two-phase, mentored career development award program that is intended to facilitate a timely transition of qualified postdoctoral fellows in the NIMH Division of Intramural Programs (DIRP) from intramural postdoctoral research positions to extramural, academic tenure-track or equivalent faculty positions at eligible U.S. institutions. Both the intramural and extramural phases will be mentored, and the award will provide research support during the extramural phase to help awardees launch competitive, independent research programs. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOA (PA-18-NNN ).

Pages